Literature DB >> 35607631

Clinical Use of Radiopharmaceuticals in Boron Neutron Capture Therapy.

Yun-Sang Lee1, Hyo Jung Seo2.   

Abstract

Entities:  

Year:  2022        PMID： 35607631      PMCID： PMC9123127          DOI： 10.1007/s13139-022-00739-5

Source DB:  PubMed          Journal:  Nucl Med Mol Imaging        ISSN： 1869-3474


× No keyword cloud information.
  13 in total

Review 1.  The radiobiological principles of boron neutron capture therapy: a critical review.

Authors:  J W Hopewell; G M Morris; A Schwint; J A Coderre
Journal:  Appl Radiat Isot       Date:  2011-04-22       Impact factor: 1.513

2.  Accumulation of boron in malignant and normal cells incubated in vitro with boronophenylalanine, mercaptoborane or boric acid.

Authors:  J Capala; M S Makar; J A Coderre
Journal:  Radiat Res       Date:  1996-11       Impact factor: 2.841

Review 3.  The radiation biology of boron neutron capture therapy.

Authors:  J A Coderre; G M Morris
Journal:  Radiat Res       Date:  1999-01       Impact factor: 2.841

4.  Subcellular localization of p-boronophenylalanine-delivered boron-10 in the rat 9L gliosarcoma: cryogenic preparation in vitro and in vivo.

Authors:  B D Bennett; J Mumford-Zisk; J A Coderre; G H Morrison
Journal:  Radiat Res       Date:  1994-10       Impact factor: 2.841

5.  Synthesis and radiation dosimetry of 4-borono-2-[18F]fluoro-D,L-phenylalanine: a target compound for PET and boron neutron capture therapy.

Authors:  K Ishiwata; T Ido; A A Mejia; M Ichihashi; Y Mishima
Journal:  Int J Rad Appl Instrum A       Date:  1991

6.  Evaluation of D-18F-FMT, 18F-FDG, L-11C-MET, and 18F-FLT for monitoring the response of tumors to radiotherapy in mice.

Authors:  Chieko Murayama; Norihiro Harada; Takeharu Kakiuchi; Dai Fukumoto; Akemi Kamijo; Akira T Kawaguchi; Hideo Tsukada
Journal:  J Nucl Med       Date:  2009-01-21       Impact factor: 10.057

Review 7.  4-Borono-2-18F-fluoro-L-phenylalanine PET for boron neutron capture therapy-oriented diagnosis: overview of a quarter century of research.

Authors:  Kiichi Ishiwata
Journal:  Ann Nucl Med       Date:  2019-02-28       Impact factor: 2.668

8.  Improved Stability and Practicality for Synthesis of 4-Borono-2-[18F]fluoro-l-phenylalanine by Combination of [18O]O2 Single-Use and [18F]CH3COOF Labeling Agents.

Authors:  Sadahiro Naka; Toshimitsu Watanabe; Yasukazu Kanai; Tadashi Watabe; Mitsuaki Tatsumi; Hiroki Kato; Eku Shimosegawa; Jun Hatazawa
Journal:  Nucl Med Mol Imaging       Date:  2022-02-08

9.  KSNM 60 years: International Collaboration with Asian Nuclear Medicine Community.

Authors:  Jun Hatazawa
Journal:  Nucl Med Mol Imaging       Date:  2021-04-02

10.  Reliable radiosynthesis of 4-[10B]borono-2-[18F]fluoro-L-phenylalanine with quality assurance for boron neutron capture therapy-oriented diagnosis.

Authors:  Kiichi Ishiwata; Ryoichi Ebinuma; Chuichi Watanabe; Kunpei Hayashi; Jun Toyohara
Journal:  Ann Nucl Med       Date:  2018-06-05       Impact factor: 2.668
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.